Literature DB >> 19622413

Transforaminal interbody fusion and the "off label" use of recombinant human bone morphogenetic protein-2.

Rahul Vaidya1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19622413     DOI: 10.1016/j.spinee.2009.05.014

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


× No keyword cloud information.
  5 in total

1.  Novel microhydroxyapatite particles in a collagen scaffold: a bioactive bone void filler?

Authors:  Frank G Lyons; John P Gleeson; Sonia Partap; Karen Coghlan; Fergal J O'Brien
Journal:  Clin Orthop Relat Res       Date:  2014-01-03       Impact factor: 4.176

2.  A comparative evaluation of factors influencing osteoinductivity among scaffolds designed for bone regeneration.

Authors:  Erin L Hsu; Jason H Ghodasra; Amruta Ashtekar; Michael S Nickoli; Sungsoo S Lee; Samuel I Stupp; Wellington K Hsu
Journal:  Tissue Eng Part A       Date:  2013-05-01       Impact factor: 3.845

Review 3.  Improving the clinical evidence of bone graft substitute technology in lumbar spine surgery.

Authors:  Wellington K Hsu; M S Nickoli; J C Wang; J R Lieberman; H S An; S T Yoon; J A Youssef; D S Brodke; C M McCullough
Journal:  Global Spine J       Date:  2012-10-09

4.  Comparison of intervertebral fusion rates of different bone graft materials in extreme lateral interbody fusion.

Authors:  Yuan Gao; Jiaqi Li; Hao Cui; Fei Zhang; Yapeng Sun; Zeyang Li; Wenyuan Ding; Yong Shen; Wei Zhang
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 5.  Designing biomaterials for the delivery of RNA therapeutics to stimulate bone healing.

Authors:  L Andrée; F Yang; R Brock; S C G Leeuwenburgh
Journal:  Mater Today Bio       Date:  2021-03-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.